Literature DB >> 32015123

High-throughput quantitative microscopy-based half-life measurements of intravenously injected agents.

Laura G Bracaglia1, Alexandra S Piotrowski-Daspit1, Chun-Yu Lin1, Zoe M Moscato1, Yongheng Wang1, Gregory T Tietjen1,2, W Mark Saltzman3,4,5.   

Abstract

Accurate analysis of blood concentration and circulation half-life is an important consideration for any intravenously administered agent in preclinical development or for therapeutic application. However, the currently available tools to measure these parameters are laborious, expensive, and inefficient for handling multiple samples from complex multivariable experiments. Here we describe a robust high-throughput quantitative microscopy-based method to measure the blood concentration and circulation half-life of any fluorescently labeled agent using only a small (2 µL) amount of blood volume, enabling additional end-point measurements to be assessed in the same subject. To validate this method, we demonstrate its use to measure the circulation half-life in mice of two types of fluorescently labeled polymeric nanoparticles of different sizes and surface chemistries and of a much smaller fluorescently labeled monoclonal antibody. Furthermore, we demonstrate the improved accuracy of this method compared to previously described methods.

Entities:  

Keywords:  circulation half-life; drug delivery; nanoparticle; quantitative microscopy

Mesh:

Substances:

Year:  2020        PMID: 32015123      PMCID: PMC7035491          DOI: 10.1073/pnas.1915450117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  21 in total

1.  Intravascular staining for discrimination of vascular and tissue leukocytes.

Authors:  Kristin G Anderson; Katrin Mayer-Barber; Heungsup Sung; Lalit Beura; Britnie R James; Justin J Taylor; Lindor Qunaj; Thomas S Griffith; Vaiva Vezys; Daniel L Barber; David Masopust
Journal:  Nat Protoc       Date:  2014-01-02       Impact factor: 13.491

2.  Surface protein engineering increases the circulation time of a cell membrane-based nanotherapeutic.

Authors:  Sangeetha Krishnamurthy; Padmalosini Muthukumaran; Muthu Kumara Gnanasammandhan Jayakumar; Domenik Lisse; Nihar D Masurkar; Chenjie Xu; Juliana M Chan; Chester L Drum
Journal:  Nanomedicine       Date:  2019-03-08       Impact factor: 5.307

3.  Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics.

Authors:  James E Dahlman; Kevin J Kauffman; Yiping Xing; Taylor E Shaw; Faryal F Mir; Chloe C Dlott; Robert Langer; Daniel G Anderson; Eric T Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-06       Impact factor: 11.205

Review 4.  The state-of-play and future of antibody therapeutics.

Authors:  Zehra Elgundi; Mouhamad Reslan; Esteban Cruz; Vicki Sifniotis; Veysel Kayser
Journal:  Adv Drug Deliv Rev       Date:  2016-12-02       Impact factor: 15.470

Review 5.  The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction.

Authors:  Nazanin Hoshyar; Samantha Gray; Hongbin Han; Gang Bao
Journal:  Nanomedicine (Lond)       Date:  2016-03-22       Impact factor: 5.307

6.  In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent.

Authors:  Charles Glaus; Raffaella Rossin; Michael J Welch; Gang Bao
Journal:  Bioconjug Chem       Date:  2010-04-21       Impact factor: 4.774

7.  A nanoparticle size series for in vivo fluorescence imaging.

Authors:  Zoran Popović; Wenhao Liu; Vikash P Chauhan; Jungmin Lee; Cliff Wong; Andrew B Greytak; Numpon Insin; Daniel G Nocera; Dai Fukumura; Rakesh K Jain; Moungi G Bawendi
Journal:  Angew Chem Int Ed Engl       Date:  2010-11-08       Impact factor: 15.336

8.  Quantitative microscopy-based measurements of circulating nanoparticle concentration using microliter blood volumes.

Authors:  Gregory T Tietjen; Jenna DiRito; Jordan S Pober; W Mark Saltzman
Journal:  Nanomedicine       Date:  2017-04-13       Impact factor: 5.307

9.  The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles.

Authors:  Yang Deng; Jennifer K Saucier-Sawyer; Christopher J Hoimes; Junwei Zhang; Young-Eun Seo; Jillian W Andrejecsk; W Mark Saltzman
Journal:  Biomaterials       Date:  2014-05-09       Impact factor: 12.479

10.  Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.

Authors:  Junzhu Wu; Jingjing Zhao; Bo Zhang; Yong Qian; Huile Gao; Yuan Yu; Yan Wei; Zhi Yang; Xinguo Jiang; Zhiqing Pang
Journal:  Int J Nanomedicine       Date:  2014-11-13
View more
  1 in total

1.  PEGylation of poly(amine-co-ester) polyplexes for tunable gene delivery.

Authors:  Molly K Grun; Alexandra Suberi; Kwangsoo Shin; Teresa Lee; Victoria Gomerdinger; Zoe M Moscato; Alexandra S Piotrowski-Daspit; W Mark Saltzman
Journal:  Biomaterials       Date:  2021-03-24       Impact factor: 15.304

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.